查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595648

蛋白质治疗市场：按蛋白质功能、产品类型划分 - 2025-2030 年全球预测

Protein Therapeutics Market by Protein Function (Enzymatic & Regulatory, Protein Diagnostics, Vaccines), Product Type (Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

蛋白质治疗市场2023年估值为786.6亿美元，预计到2024年将达到848亿美元，复合年增长率为7.90%，预计到2030年将达到1339.8亿美元。

蛋白质疗法包括源自工程蛋白质的多种治疗方法，例如单株抗体、胰岛素和融合蛋白，主要针对各种疾病，例如癌症、荷尔蒙失调和自体免疫疾病。与传统治疗方法相比，这些治疗方法由于其特异性、有效性和副作用减少而在现代医学中发挥重要作用。慢性疾病的日益流行和个人化医疗的需求推动了对蛋白质疗法的需求，其应用涵盖肿瘤学、罕见疾病和代谢疾病。这些治疗方法被製药公司、研究机构和医疗保健提供者广泛使用，旨在提供标靶治疗选择。重组 DNA 技术的进步和 FDA 对生物治疗产品的核准不断增加，推动了市场成长。生物製药公司正专注于扩大其临床管道并投资于生物加工能力，以满足不断增长的需求。潜在的市场开拓机会在于生物相似药市场的扩张以及医疗基础设施快速发展的新兴经济体的成长。然而，高开发成本、严格的法律规范和製造复杂性等挑战可能会阻碍市场成长。此外，智慧财产权问题和小分子药物的竞争也构成了进一步的障碍。药物开发中的人工智慧和机器学习、新颖的给药机制以及个人化医疗的兴起等创新为业务成长提供了巨大的潜力。研究和开发研究人员应该寻求创新的製造技术，例如连续处理和一次性系统，以提高可扩展性和成本效率。市场动态是动态的，其特点是技术进步和对研发的重视。对于想要驾驭这一格局的公司来说，策略伙伴关係和协作对于有效利用专业知识和资源以确保竞争优势和持续的市场相关性至关重要。

主要市场统计
基准年[2023] 786.6亿美元
预测年份 [2024] 848亿美元
预测年份 [2030] 1339.8亿美元
复合年增长率（%） 7.90%

市场动态：揭示快速发展的蛋白质治疗市场的关键市场洞察

蛋白质治疗市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 新兴市场医疗保健支出不断增加
    • 政府努力改善医疗服务
    • 老年人口增加和慢性病增加
  • 市场限制因素
    • 蛋白质疗法的局限性，例如由于大蛋白质导致生产成本高和组织渗透效率低
    • 由于口服药物在肠道中变性，因此对其可得性的担忧
  • 市场机会
    • 双特异性单株抗体的潜力
    • 新兴国家未满足的需求
  • 市场挑战
    • 製造和处理成本高
    • 与生物相似药的竞争

波特的五力策略工具引领蛋白质治疗市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解蛋白质治疗市场的外部影响

外部宏观环境因素在塑造蛋白质治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解蛋白质治疗药物市场的竞争格局

蛋白质治疗市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位基质蛋白治疗市场供应商的绩效评估

FPNV定位矩阵是评估蛋白质治疗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製蛋白质治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，蛋白质治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 新兴市场医疗保健成本上升
      • 政府努力改善医疗服务
      • 老年人口增加和慢性病增加
    • 抑制因素
      • 由于蛋白质尺寸较大，蛋白质疗法具有生产成本高、组织渗透效率低等限制。
      • 由于肠道变性，人们担心其用作口服药物的可能性。
    • 机会
      • 双特异性单株抗体的潜力
      • 新兴国家未满足的医疗需求
    • 任务
      • 生产和处理成本高
      • 与生物相似药的竞争
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依蛋白质功能分類的蛋白质治疗药物市场

  • 酵素和调节
  • 蛋白质诊断
  • 疫苗

第七章蛋白质治疗市场：依产品类型

  • 凝血因子
  • 促红血球生成素
  • 滤泡刺激素
  • G-CSF
  • 胰岛素
  • 干扰素
  • 单株抗体

第八章美洲蛋白质治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太蛋白质治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的蛋白质治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Ambrx, Inc.
  • Amgen,Inc.
  • Aravive, Inc.
  • AstraZeneca Plc
  • Atomwise Inc.
  • Autolus Therapeutics Plc
  • Baxter International, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • LabGenius Limited
  • LGC Group
  • Merck & Co. Inc.
  • Morphic Therapeutic, Inc.
  • Omeros Corporation
  • Pfizer, Inc.
  • Sanofi SA
Product Code: MRR-035AB9C0DA41

The Protein Therapeutics Market was valued at USD 78.66 billion in 2023, expected to reach USD 84.80 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 133.98 billion by 2030.

Protein therapeutics encompass a spectrum of treatment modalities derived from engineered proteins, including monoclonal antibodies, insulin, and fusion proteins, primarily targeting a range of diseases such as cancer, hormonal disorders, and autoimmune diseases. These therapies play a crucial role in modern medicine due to their specificity, potency, and reduced side effects compared to traditional treatments. The necessity for protein therapeutics is driven by the increasing prevalence of chronic diseases and the need for personalized medicine, with applications spanning oncology, rare diseases, and metabolic disorders. These therapies are extensively used by pharmaceutical companies, research institutions, and healthcare providers aiming to deliver targeted treatment options. Market growth is propelled by advancements in recombinant DNA technology and an increasing number of FDA approvals for biotherapeutic products. Biopharmaceutical companies are focusing on expanding their clinical pipelines and investing in bioprocessing capabilities to meet the increasing demand. Potential opportunities lie in the expanding biosimilars market and growth in emerging economies where healthcare infrastructure is rapidly developing. However, challenges such as high development costs, stringent regulatory frameworks, and the complexity involved in manufacturing can hinder market growth. Moreover, intellectual property issues and competition from small molecule drugs present additional barriers. Innovations such as AI and machine learning in drug development, novel delivery mechanisms, and the rise of personalized medicine offer significant potential for business growth. Researchers and developers should focus on innovative manufacturing techniques like continuous processing and single-use systems to improve scalability and cost-efficiency. The protein therapeutics market is dynamic, characterized by technological advancements and a strong emphasis on R&D. As companies navigate this landscape, strategic partnerships and collaborations will be essential to leverage expertise and resources effectively, ensuring competitive advantage and sustained market relevance.

KEY MARKET STATISTICS
Base Year [2023] USD 78.66 billion
Estimated Year [2024] USD 84.80 billion
Forecast Year [2030] USD 133.98 billion
CAGR (%) 7.90%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Therapeutics Market

The Protein Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing healthcare expenditure in the emerging markets
    • Government initiatives to improve the healthcare services
    • Growing geriatric population & rising predominance of chronic diseases
  • Market Restraints
    • Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
    • Availability concerns as oral drugs due to denaturation in the gut
  • Market Opportunities
    • Potential for bispecific monoclonal antibodies
    • Unmet medical needs in developing countries
  • Market Challenges
    • High cost of production and treatment
    • Competition from biosimilars

Porter's Five Forces: A Strategic Tool for Navigating the Protein Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Therapeutics Market

A detailed market share analysis in the Protein Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Therapeutics Market

A strategic analysis of the Protein Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Ambrx, Inc., Amgen,Inc., Aravive, Inc., AstraZeneca Plc, Atomwise Inc., Autolus Therapeutics Plc, Baxter International, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Genentech, Inc., LabGenius Limited, LGC Group, Merck & Co. Inc., Morphic Therapeutic, Inc., Omeros Corporation, Pfizer, Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Protein Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Protein Function, market is studied across Enzymatic & Regulatory, Protein Diagnostics, and Vaccines.
  • Based on Product Type, market is studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing healthcare expenditure in the emerging markets
      • 5.1.1.2. Government initiatives to improve the healthcare services
      • 5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
      • 5.1.2.2. Availability concerns as oral drugs due to denaturation in the gut
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential for bispecific monoclonal antibodies
      • 5.1.3.2. Unmet medical needs in developing countries
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of production and treatment
      • 5.1.4.2. Competition from biosimilars
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Protein Therapeutics Market, by Protein Function

  • 6.1. Introduction
  • 6.2. Enzymatic & Regulatory
  • 6.3. Protein Diagnostics
  • 6.4. Vaccines

7. Protein Therapeutics Market, by Product Type

  • 7.1. Introduction
  • 7.2. Blood Clotting Factor
  • 7.3. Erythropoietin
  • 7.4. Follicle Stimulating Hormone
  • 7.5. G-CSF
  • 7.6. Insulin
  • 7.7. Interferons
  • 7.8. Monoclonal Antibodies

8. Americas Protein Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Protein Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Protein Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ambrx, Inc.
  • 2. Amgen,Inc.
  • 3. Aravive, Inc.
  • 4. AstraZeneca Plc
  • 5. Atomwise Inc.
  • 6. Autolus Therapeutics Plc
  • 7. Baxter International, Inc.
  • 8. Eli Lilly and Company
  • 9. F. Hoffmann-La Roche AG
  • 10. Genentech, Inc.
  • 11. LabGenius Limited
  • 12. LGC Group
  • 13. Merck & Co. Inc.
  • 14. Morphic Therapeutic, Inc.
  • 15. Omeros Corporation
  • 16. Pfizer, Inc.
  • 17. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. PROTEIN THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. PROTEIN THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PROTEIN THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PROTEIN THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC & REGULATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023